PMC:7105881 / 41051-46467
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1363","span":{"begin":277,"end":281},"obj":"Gene"},{"id":"1364","span":{"begin":731,"end":735},"obj":"Gene"},{"id":"1365","span":{"begin":737,"end":742},"obj":"Gene"},{"id":"1366","span":{"begin":748,"end":753},"obj":"Gene"},{"id":"1367","span":{"begin":930,"end":935},"obj":"Gene"},{"id":"1368","span":{"begin":937,"end":942},"obj":"Gene"},{"id":"1369","span":{"begin":944,"end":948},"obj":"Gene"},{"id":"1370","span":{"begin":950,"end":954},"obj":"Gene"},{"id":"1371","span":{"begin":956,"end":960},"obj":"Gene"},{"id":"1372","span":{"begin":966,"end":971},"obj":"Gene"},{"id":"1373","span":{"begin":1205,"end":1209},"obj":"Gene"},{"id":"1374","span":{"begin":1332,"end":1336},"obj":"Gene"},{"id":"1375","span":{"begin":1338,"end":1343},"obj":"Gene"},{"id":"1376","span":{"begin":1349,"end":1353},"obj":"Gene"},{"id":"1377","span":{"begin":1481,"end":1486},"obj":"Gene"},{"id":"1378","span":{"begin":1491,"end":1495},"obj":"Gene"},{"id":"1379","span":{"begin":1582,"end":1586},"obj":"Gene"},{"id":"1380","span":{"begin":1727,"end":1732},"obj":"Gene"},{"id":"1381","span":{"begin":1816,"end":1820},"obj":"Gene"},{"id":"1382","span":{"begin":1826,"end":1831},"obj":"Gene"},{"id":"1383","span":{"begin":2012,"end":2017},"obj":"Gene"},{"id":"1384","span":{"begin":2022,"end":2026},"obj":"Gene"},{"id":"1385","span":{"begin":2061,"end":2066},"obj":"Gene"},{"id":"1386","span":{"begin":2123,"end":2128},"obj":"Gene"},{"id":"1387","span":{"begin":2405,"end":2409},"obj":"Gene"},{"id":"1388","span":{"begin":2536,"end":2541},"obj":"Gene"},{"id":"1389","span":{"begin":2600,"end":2604},"obj":"Gene"},{"id":"1390","span":{"begin":2610,"end":2615},"obj":"Gene"},{"id":"1391","span":{"begin":2761,"end":2766},"obj":"Gene"},{"id":"1392","span":{"begin":2888,"end":2892},"obj":"Gene"},{"id":"1393","span":{"begin":3012,"end":3017},"obj":"Gene"},{"id":"1394","span":{"begin":3143,"end":3148},"obj":"Gene"},{"id":"1395","span":{"begin":3402,"end":3406},"obj":"Gene"},{"id":"1396","span":{"begin":3612,"end":3636},"obj":"Gene"},{"id":"1397","span":{"begin":4116,"end":4121},"obj":"Gene"},{"id":"1398","span":{"begin":4160,"end":4163},"obj":"Gene"},{"id":"1399","span":{"begin":4315,"end":4320},"obj":"Gene"},{"id":"1400","span":{"begin":4322,"end":4326},"obj":"Gene"},{"id":"1401","span":{"begin":4328,"end":4332},"obj":"Gene"},{"id":"1402","span":{"begin":4334,"end":4339},"obj":"Gene"},{"id":"1403","span":{"begin":4345,"end":4351},"obj":"Gene"},{"id":"1404","span":{"begin":4547,"end":4550},"obj":"Gene"},{"id":"1405","span":{"begin":4386,"end":4391},"obj":"Gene"},{"id":"1406","span":{"begin":4646,"end":4649},"obj":"Gene"},{"id":"1407","span":{"begin":3718,"end":3721},"obj":"Gene"},{"id":"1408","span":{"begin":3381,"end":3384},"obj":"Gene"},{"id":"1409","span":{"begin":3048,"end":3051},"obj":"Gene"},{"id":"1410","span":{"begin":2580,"end":2583},"obj":"Gene"},{"id":"1411","span":{"begin":1788,"end":1791},"obj":"Gene"},{"id":"1412","span":{"begin":1307,"end":1310},"obj":"Gene"},{"id":"1413","span":{"begin":713,"end":716},"obj":"Gene"},{"id":"1414","span":{"begin":428,"end":431},"obj":"Gene"},{"id":"1415","span":{"begin":218,"end":226},"obj":"Species"},{"id":"1416","span":{"begin":295,"end":303},"obj":"Species"},{"id":"1417","span":{"begin":401,"end":405},"obj":"Species"},{"id":"1418","span":{"begin":435,"end":439},"obj":"Species"},{"id":"1419","span":{"begin":468,"end":476},"obj":"Species"},{"id":"1420","span":{"begin":536,"end":544},"obj":"Species"},{"id":"1421","span":{"begin":629,"end":634},"obj":"Species"},{"id":"1422","span":{"begin":671,"end":675},"obj":"Species"},{"id":"1423","span":{"begin":691,"end":699},"obj":"Species"},{"id":"1424","span":{"begin":797,"end":802},"obj":"Species"},{"id":"1425","span":{"begin":846,"end":854},"obj":"Species"},{"id":"1426","span":{"begin":881,"end":889},"obj":"Species"},{"id":"1427","span":{"begin":976,"end":980},"obj":"Species"},{"id":"1428","span":{"begin":1050,"end":1058},"obj":"Species"},{"id":"1429","span":{"begin":1263,"end":1267},"obj":"Species"},{"id":"1430","span":{"begin":1277,"end":1285},"obj":"Species"},{"id":"1431","span":{"begin":1358,"end":1362},"obj":"Species"},{"id":"1432","span":{"begin":1398,"end":1406},"obj":"Species"},{"id":"1433","span":{"begin":1433,"end":1441},"obj":"Species"},{"id":"1434","span":{"begin":1500,"end":1504},"obj":"Species"},{"id":"1435","span":{"begin":1600,"end":1608},"obj":"Species"},{"id":"1436","span":{"begin":1721,"end":1725},"obj":"Species"},{"id":"1437","span":{"begin":1736,"end":1740},"obj":"Species"},{"id":"1438","span":{"begin":1742,"end":1749},"obj":"Species"},{"id":"1439","span":{"begin":1759,"end":1767},"obj":"Species"},{"id":"1440","span":{"begin":1911,"end":1919},"obj":"Species"},{"id":"1441","span":{"begin":1964,"end":1972},"obj":"Species"},{"id":"1442","span":{"begin":2031,"end":2035},"obj":"Species"},{"id":"1443","span":{"begin":2085,"end":2089},"obj":"Species"},{"id":"1444","span":{"begin":2132,"end":2136},"obj":"Species"},{"id":"1445","span":{"begin":2142,"end":2150},"obj":"Species"},{"id":"1446","span":{"begin":2423,"end":2431},"obj":"Species"},{"id":"1447","span":{"begin":2530,"end":2534},"obj":"Species"},{"id":"1448","span":{"begin":2545,"end":2549},"obj":"Species"},{"id":"1449","span":{"begin":2559,"end":2567},"obj":"Species"},{"id":"1450","span":{"begin":2620,"end":2624},"obj":"Species"},{"id":"1451","span":{"begin":2691,"end":2699},"obj":"Species"},{"id":"1452","span":{"begin":2770,"end":2774},"obj":"Species"},{"id":"1453","span":{"begin":2793,"end":2801},"obj":"Species"},{"id":"1454","span":{"begin":2897,"end":2905},"obj":"Species"},{"id":"1455","span":{"begin":3006,"end":3010},"obj":"Species"},{"id":"1456","span":{"begin":3021,"end":3025},"obj":"Species"},{"id":"1457","span":{"begin":3069,"end":3073},"obj":"Species"},{"id":"1458","span":{"begin":3087,"end":3095},"obj":"Species"},{"id":"1459","span":{"begin":3152,"end":3156},"obj":"Species"},{"id":"1460","span":{"begin":3175,"end":3183},"obj":"Species"},{"id":"1461","span":{"begin":3265,"end":3273},"obj":"Species"},{"id":"1462","span":{"begin":3340,"end":3344},"obj":"Species"},{"id":"1463","span":{"begin":3360,"end":3368},"obj":"Species"},{"id":"1464","span":{"begin":3460,"end":3468},"obj":"Species"},{"id":"1465","span":{"begin":3536,"end":3544},"obj":"Species"},{"id":"1466","span":{"begin":3670,"end":3679},"obj":"Species"},{"id":"1467","span":{"begin":3680,"end":3686},"obj":"Species"},{"id":"1468","span":{"begin":3688,"end":3695},"obj":"Species"},{"id":"1469","span":{"begin":3725,"end":3734},"obj":"Species"},{"id":"1470","span":{"begin":3735,"end":3741},"obj":"Species"},{"id":"1471","span":{"begin":3755,"end":3762},"obj":"Species"},{"id":"1472","span":{"begin":3792,"end":3800},"obj":"Species"},{"id":"1473","span":{"begin":3844,"end":3853},"obj":"Species"},{"id":"1474","span":{"begin":3854,"end":3860},"obj":"Species"},{"id":"1475","span":{"begin":3865,"end":3872},"obj":"Species"},{"id":"1476","span":{"begin":3891,"end":3899},"obj":"Species"},{"id":"1477","span":{"begin":3994,"end":4000},"obj":"Species"},{"id":"1478","span":{"begin":4029,"end":4036},"obj":"Species"},{"id":"1479","span":{"begin":4106,"end":4110},"obj":"Species"},{"id":"1480","span":{"begin":4122,"end":4126},"obj":"Species"},{"id":"1481","span":{"begin":4136,"end":4144},"obj":"Species"},{"id":"1482","span":{"begin":4182,"end":4186},"obj":"Species"},{"id":"1483","span":{"begin":4229,"end":4237},"obj":"Species"},{"id":"1484","span":{"begin":4264,"end":4272},"obj":"Species"},{"id":"1485","span":{"begin":4356,"end":4360},"obj":"Species"},{"id":"1486","span":{"begin":4403,"end":4407},"obj":"Species"},{"id":"1487","span":{"begin":4426,"end":4434},"obj":"Species"},{"id":"1488","span":{"begin":4599,"end":4603},"obj":"Species"},{"id":"1489","span":{"begin":4609,"end":4616},"obj":"Species"},{"id":"1490","span":{"begin":4626,"end":4634},"obj":"Species"},{"id":"1491","span":{"begin":4666,"end":4673},"obj":"Species"},{"id":"1492","span":{"begin":4700,"end":4708},"obj":"Species"},{"id":"1493","span":{"begin":720,"end":724},"obj":"Species"},{"id":"1494","span":{"begin":1795,"end":1799},"obj":"Species"},{"id":"1495","span":{"begin":1837,"end":1844},"obj":"Species"},{"id":"1496","span":{"begin":3388,"end":3392},"obj":"Species"},{"id":"1497","span":{"begin":1110,"end":1119},"obj":"Disease"},{"id":"1498","span":{"begin":2228,"end":2250},"obj":"Disease"},{"id":"1499","span":{"begin":3581,"end":3602},"obj":"Disease"},{"id":"1500","span":{"begin":4474,"end":4492},"obj":"Disease"},{"id":"1501","span":{"begin":2854,"end":2859},"obj":"Mutation"}],"attributes":[{"id":"A1363","pred":"tao:has_database_id","subj":"1363","obj":"Gene:1803"},{"id":"A1364","pred":"tao:has_database_id","subj":"1364","obj":"Gene:16017"},{"id":"A1365","pred":"tao:has_database_id","subj":"1365","obj":"Gene:668478"},{"id":"A1366","pred":"tao:has_database_id","subj":"1366","obj":"Gene:16016"},{"id":"A1367","pred":"tao:has_database_id","subj":"1367","obj":"Gene:3458"},{"id":"A1368","pred":"tao:has_database_id","subj":"1368","obj":"Gene:7124"},{"id":"A1369","pred":"tao:has_database_id","subj":"1369","obj":"Gene:3558"},{"id":"A1370","pred":"tao:has_database_id","subj":"1370","obj":"Gene:3565"},{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"Gene:3569"},{"id":"A1372","pred":"tao:has_database_id","subj":"1372","obj":"Gene:3586"},{"id":"A1373","pred":"tao:has_database_id","subj":"1373","obj":"Gene:1803"},{"id":"A1374","pred":"tao:has_database_id","subj":"1374","obj":"Gene:16017"},{"id":"A1375","pred":"tao:has_database_id","subj":"1375","obj":"Gene:668478"},{"id":"A1376","pred":"tao:has_database_id","subj":"1376","obj":"Gene:3502"},{"id":"A1377","pred":"tao:has_database_id","subj":"1377","obj":"Gene:3458"},{"id":"A1378","pred":"tao:has_database_id","subj":"1378","obj":"Gene:3558"},{"id":"A1379","pred":"tao:has_database_id","subj":"1379","obj":"Gene:13482"},{"id":"A1380","pred":"tao:has_database_id","subj":"1380","obj":"Gene:1803"},{"id":"A1381","pred":"tao:has_database_id","subj":"1381","obj":"Gene:16017"},{"id":"A1382","pred":"tao:has_database_id","subj":"1382","obj":"Gene:668478"},{"id":"A1383","pred":"tao:has_database_id","subj":"1383","obj":"Gene:3458"},{"id":"A1384","pred":"tao:has_database_id","subj":"1384","obj":"Gene:3558"},{"id":"A1385","pred":"tao:has_database_id","subj":"1385","obj":"Gene:1803"},{"id":"A1386","pred":"tao:has_database_id","subj":"1386","obj":"Gene:1803"},{"id":"A1387","pred":"tao:has_database_id","subj":"1387","obj":"Gene:1803"},{"id":"A1388","pred":"tao:has_database_id","subj":"1388","obj":"Gene:1803"},{"id":"A1389","pred":"tao:has_database_id","subj":"1389","obj":"Gene:16017"},{"id":"A1390","pred":"tao:has_database_id","subj":"1390","obj":"Gene:668478"},{"id":"A1391","pred":"tao:has_database_id","subj":"1391","obj":"Gene:1803"},{"id":"A1392","pred":"tao:has_database_id","subj":"1392","obj":"Gene:1803"},{"id":"A1393","pred":"tao:has_database_id","subj":"1393","obj":"Gene:1803"},{"id":"A1394","pred":"tao:has_database_id","subj":"1394","obj":"Gene:1803"},{"id":"A1395","pred":"tao:has_database_id","subj":"1395","obj":"Gene:16017"},{"id":"A1396","pred":"tao:has_database_id","subj":"1396","obj":"Gene:7276"},{"id":"A1397","pred":"tao:has_database_id","subj":"1397","obj":"Gene:1803"},{"id":"A1398","pred":"tao:has_database_id","subj":"1398","obj":"Gene:51428"},{"id":"A1399","pred":"tao:has_database_id","subj":"1399","obj":"Gene:3458"},{"id":"A1400","pred":"tao:has_database_id","subj":"1400","obj":"Gene:3558"},{"id":"A1401","pred":"tao:has_database_id","subj":"1401","obj":"Gene:3569"},{"id":"A1402","pred":"tao:has_database_id","subj":"1402","obj":"Gene:3586"},{"id":"A1403","pred":"tao:has_database_id","subj":"1403","obj":"Gene:3605"},{"id":"A1404","pred":"tao:has_database_id","subj":"1404","obj":"Gene:6670"},{"id":"A1405","pred":"tao:has_database_id","subj":"1405","obj":"Gene:1803"},{"id":"A1406","pred":"tao:has_database_id","subj":"1406","obj":"Gene:51428"},{"id":"A1407","pred":"tao:has_database_id","subj":"1407","obj":"Gene:72935"},{"id":"A1408","pred":"tao:has_database_id","subj":"1408","obj":"Gene:51428"},{"id":"A1409","pred":"tao:has_database_id","subj":"1409","obj":"Gene:72935"},{"id":"A1410","pred":"tao:has_database_id","subj":"1410","obj":"Gene:51428"},{"id":"A1411","pred":"tao:has_database_id","subj":"1411","obj":"Gene:51428"},{"id":"A1412","pred":"tao:has_database_id","subj":"1412","obj":"Gene:51428"},{"id":"A1413","pred":"tao:has_database_id","subj":"1413","obj":"Gene:51428"},{"id":"A1414","pred":"tao:has_database_id","subj":"1414","obj":"Gene:72935"},{"id":"A1415","pred":"tao:has_database_id","subj":"1415","obj":"Tax:1335626"},{"id":"A1416","pred":"tao:has_database_id","subj":"1416","obj":"Tax:1335626"},{"id":"A1417","pred":"tao:has_database_id","subj":"1417","obj":"Tax:10090"},{"id":"A1418","pred":"tao:has_database_id","subj":"1418","obj":"Tax:10090"},{"id":"A1419","pred":"tao:has_database_id","subj":"1419","obj":"Tax:1335626"},{"id":"A1420","pred":"tao:has_database_id","subj":"1420","obj":"Tax:1335626"},{"id":"A1421","pred":"tao:has_database_id","subj":"1421","obj":"Tax:10090"},{"id":"A1422","pred":"tao:has_database_id","subj":"1422","obj":"Tax:10090"},{"id":"A1423","pred":"tao:has_database_id","subj":"1423","obj":"Tax:1335626"},{"id":"A1424","pred":"tao:has_database_id","subj":"1424","obj":"Tax:10090"},{"id":"A1425","pred":"tao:has_database_id","subj":"1425","obj":"Tax:1335626"},{"id":"A1426","pred":"tao:has_database_id","subj":"1426","obj":"Tax:1335626"},{"id":"A1427","pred":"tao:has_database_id","subj":"1427","obj":"Tax:10090"},{"id":"A1428","pred":"tao:has_database_id","subj":"1428","obj":"Tax:1335626"},{"id":"A1429","pred":"tao:has_database_id","subj":"1429","obj":"Tax:10090"},{"id":"A1430","pred":"tao:has_database_id","subj":"1430","obj":"Tax:1335626"},{"id":"A1431","pred":"tao:has_database_id","subj":"1431","obj":"Tax:10090"},{"id":"A1432","pred":"tao:has_database_id","subj":"1432","obj":"Tax:1335626"},{"id":"A1433","pred":"tao:has_database_id","subj":"1433","obj":"Tax:1335626"},{"id":"A1434","pred":"tao:has_database_id","subj":"1434","obj":"Tax:10090"},{"id":"A1435","pred":"tao:has_database_id","subj":"1435","obj":"Tax:1335626"},{"id":"A1436","pred":"tao:has_database_id","subj":"1436","obj":"Tax:10090"},{"id":"A1437","pred":"tao:has_database_id","subj":"1437","obj":"Tax:10090"},{"id":"A1438","pred":"tao:has_database_id","subj":"1438","obj":"Tax:9986"},{"id":"A1439","pred":"tao:has_database_id","subj":"1439","obj":"Tax:1335626"},{"id":"A1440","pred":"tao:has_database_id","subj":"1440","obj":"Tax:1335626"},{"id":"A1441","pred":"tao:has_database_id","subj":"1441","obj":"Tax:1335626"},{"id":"A1442","pred":"tao:has_database_id","subj":"1442","obj":"Tax:10090"},{"id":"A1443","pred":"tao:has_database_id","subj":"1443","obj":"Tax:10090"},{"id":"A1444","pred":"tao:has_database_id","subj":"1444","obj":"Tax:10090"},{"id":"A1445","pred":"tao:has_database_id","subj":"1445","obj":"Tax:1335626"},{"id":"A1446","pred":"tao:has_database_id","subj":"1446","obj":"Tax:1335626"},{"id":"A1447","pred":"tao:has_database_id","subj":"1447","obj":"Tax:10090"},{"id":"A1448","pred":"tao:has_database_id","subj":"1448","obj":"Tax:10090"},{"id":"A1449","pred":"tao:has_database_id","subj":"1449","obj":"Tax:1335626"},{"id":"A1450","pred":"tao:has_database_id","subj":"1450","obj":"Tax:10090"},{"id":"A1451","pred":"tao:has_database_id","subj":"1451","obj":"Tax:1335626"},{"id":"A1452","pred":"tao:has_database_id","subj":"1452","obj":"Tax:10090"},{"id":"A1453","pred":"tao:has_database_id","subj":"1453","obj":"Tax:1335626"},{"id":"A1454","pred":"tao:has_database_id","subj":"1454","obj":"Tax:1335626"},{"id":"A1455","pred":"tao:has_database_id","subj":"1455","obj":"Tax:10090"},{"id":"A1456","pred":"tao:has_database_id","subj":"1456","obj":"Tax:10090"},{"id":"A1457","pred":"tao:has_database_id","subj":"1457","obj":"Tax:10090"},{"id":"A1458","pred":"tao:has_database_id","subj":"1458","obj":"Tax:1335626"},{"id":"A1459","pred":"tao:has_database_id","subj":"1459","obj":"Tax:10090"},{"id":"A1460","pred":"tao:has_database_id","subj":"1460","obj":"Tax:1335626"},{"id":"A1461","pred":"tao:has_database_id","subj":"1461","obj":"Tax:1335626"},{"id":"A1462","pred":"tao:has_database_id","subj":"1462","obj":"Tax:10090"},{"id":"A1463","pred":"tao:has_database_id","subj":"1463","obj":"Tax:1335626"},{"id":"A1464","pred":"tao:has_database_id","subj":"1464","obj":"Tax:1335626"},{"id":"A1465","pred":"tao:has_database_id","subj":"1465","obj":"Tax:1335626"},{"id":"A1466","pred":"tao:has_database_id","subj":"1466","obj":"Tax:9838"},{"id":"A1467","pred":"tao:has_database_id","subj":"1467","obj":"Tax:9838"},{"id":"A1468","pred":"tao:has_database_id","subj":"1468","obj":"Tax:30538"},{"id":"A1469","pred":"tao:has_database_id","subj":"1469","obj":"Tax:9838"},{"id":"A1470","pred":"tao:has_database_id","subj":"1470","obj":"Tax:9838"},{"id":"A1471","pred":"tao:has_database_id","subj":"1471","obj":"Tax:30538"},{"id":"A1472","pred":"tao:has_database_id","subj":"1472","obj":"Tax:1335626"},{"id":"A1473","pred":"tao:has_database_id","subj":"1473","obj":"Tax:9838"},{"id":"A1474","pred":"tao:has_database_id","subj":"1474","obj":"Tax:9838"},{"id":"A1475","pred":"tao:has_database_id","subj":"1475","obj":"Tax:30538"},{"id":"A1476","pred":"tao:has_database_id","subj":"1476","obj":"Tax:1335626"},{"id":"A1477","pred":"tao:has_database_id","subj":"1477","obj":"Tax:9838"},{"id":"A1478","pred":"tao:has_database_id","subj":"1478","obj":"Tax:30538"},{"id":"A1479","pred":"tao:has_database_id","subj":"1479","obj":"Tax:10090"},{"id":"A1480","pred":"tao:has_database_id","subj":"1480","obj":"Tax:10090"},{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"Tax:1335626"},{"id":"A1482","pred":"tao:has_database_id","subj":"1482","obj":"Tax:10090"},{"id":"A1483","pred":"tao:has_database_id","subj":"1483","obj":"Tax:1335626"},{"id":"A1484","pred":"tao:has_database_id","subj":"1484","obj":"Tax:1335626"},{"id":"A1485","pred":"tao:has_database_id","subj":"1485","obj":"Tax:10090"},{"id":"A1486","pred":"tao:has_database_id","subj":"1486","obj":"Tax:10090"},{"id":"A1487","pred":"tao:has_database_id","subj":"1487","obj":"Tax:1335626"},{"id":"A1488","pred":"tao:has_database_id","subj":"1488","obj":"Tax:10090"},{"id":"A1489","pred":"tao:has_database_id","subj":"1489","obj":"Tax:9986"},{"id":"A1490","pred":"tao:has_database_id","subj":"1490","obj":"Tax:1335626"},{"id":"A1491","pred":"tao:has_database_id","subj":"1491","obj":"Tax:9986"},{"id":"A1492","pred":"tao:has_database_id","subj":"1492","obj":"Tax:1335626"},{"id":"A1493","pred":"tao:has_database_id","subj":"1493","obj":"Tax:10090"},{"id":"A1494","pred":"tao:has_database_id","subj":"1494","obj":"Tax:10090"},{"id":"A1495","pred":"tao:has_database_id","subj":"1495","obj":"Tax:9986"},{"id":"A1496","pred":"tao:has_database_id","subj":"1496","obj":"Tax:10090"},{"id":"A1497","pred":"tao:has_database_id","subj":"1497","obj":"MESH:D011014"},{"id":"A1498","pred":"tao:has_database_id","subj":"1498","obj":"MESH:D007154"},{"id":"A1499","pred":"tao:has_database_id","subj":"1499","obj":"MESH:D015354"},{"id":"A1500","pred":"tao:has_database_id","subj":"1500","obj":"MESH:D008171"},{"id":"A1501","pred":"tao:has_standard_notation","subj":"1501","obj":"p.T579N"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T244","span":{"begin":115,"end":123},"obj":"Body_part"},{"id":"T245","span":{"begin":241,"end":248},"obj":"Body_part"},{"id":"T246","span":{"begin":259,"end":266},"obj":"Body_part"},{"id":"T247","span":{"begin":549,"end":556},"obj":"Body_part"},{"id":"T248","span":{"begin":573,"end":580},"obj":"Body_part"},{"id":"T249","span":{"begin":726,"end":729},"obj":"Body_part"},{"id":"T250","span":{"begin":765,"end":768},"obj":"Body_part"},{"id":"T251","span":{"begin":944,"end":948},"obj":"Body_part"},{"id":"T252","span":{"begin":1187,"end":1194},"obj":"Body_part"},{"id":"T253","span":{"begin":1312,"end":1315},"obj":"Body_part"},{"id":"T254","span":{"begin":1317,"end":1320},"obj":"Body_part"},{"id":"T255","span":{"begin":1491,"end":1495},"obj":"Body_part"},{"id":"T256","span":{"begin":1564,"end":1571},"obj":"Body_part"},{"id":"T257","span":{"begin":1801,"end":1804},"obj":"Body_part"},{"id":"T258","span":{"begin":1846,"end":1849},"obj":"Body_part"},{"id":"T259","span":{"begin":2022,"end":2026},"obj":"Body_part"},{"id":"T260","span":{"begin":2254,"end":2266},"obj":"Body_part"},{"id":"T261","span":{"begin":2387,"end":2394},"obj":"Body_part"},{"id":"T262","span":{"begin":2585,"end":2588},"obj":"Body_part"},{"id":"T263","span":{"begin":2861,"end":2868},"obj":"Body_part"},{"id":"T264","span":{"begin":3276,"end":3283},"obj":"Body_part"},{"id":"T265","span":{"begin":3297,"end":3304},"obj":"Body_part"},{"id":"T266","span":{"begin":3394,"end":3397},"obj":"Body_part"},{"id":"T267","span":{"begin":3418,"end":3421},"obj":"Body_part"},{"id":"T268","span":{"begin":3606,"end":3611},"obj":"Body_part"},{"id":"T269","span":{"begin":3637,"end":3644},"obj":"Body_part"},{"id":"T270","span":{"begin":4063,"end":4070},"obj":"Body_part"},{"id":"T271","span":{"begin":4165,"end":4168},"obj":"Body_part"},{"id":"T272","span":{"begin":4322,"end":4326},"obj":"Body_part"},{"id":"T273","span":{"begin":4474,"end":4478},"obj":"Body_part"},{"id":"T274","span":{"begin":4497,"end":4514},"obj":"Body_part"},{"id":"T275","span":{"begin":4651,"end":4654},"obj":"Body_part"},{"id":"T276","span":{"begin":4744,"end":4754},"obj":"Body_part"},{"id":"T277","span":{"begin":5343,"end":5349},"obj":"Body_part"}],"attributes":[{"id":"A244","pred":"fma_id","subj":"T244","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A245","pred":"fma_id","subj":"T245","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A246","pred":"fma_id","subj":"T246","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A247","pred":"fma_id","subj":"T247","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A248","pred":"fma_id","subj":"T248","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A249","pred":"fma_id","subj":"T249","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A250","pred":"fma_id","subj":"T250","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A251","pred":"fma_id","subj":"T251","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A252","pred":"fma_id","subj":"T252","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A253","pred":"fma_id","subj":"T253","obj":"http://purl.org/sig/ont/fma/fma62874"},{"id":"A254","pred":"fma_id","subj":"T254","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A255","pred":"fma_id","subj":"T255","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A256","pred":"fma_id","subj":"T256","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A257","pred":"fma_id","subj":"T257","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A258","pred":"fma_id","subj":"T258","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A259","pred":"fma_id","subj":"T259","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A260","pred":"fma_id","subj":"T260","obj":"http://purl.org/sig/ont/fma/fma62861"},{"id":"A261","pred":"fma_id","subj":"T261","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A262","pred":"fma_id","subj":"T262","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A263","pred":"fma_id","subj":"T263","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A264","pred":"fma_id","subj":"T264","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A265","pred":"fma_id","subj":"T265","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A266","pred":"fma_id","subj":"T266","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A267","pred":"fma_id","subj":"T267","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A268","pred":"fma_id","subj":"T268","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A269","pred":"fma_id","subj":"T269","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A270","pred":"fma_id","subj":"T270","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A271","pred":"fma_id","subj":"T271","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A272","pred":"fma_id","subj":"T272","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A273","pred":"fma_id","subj":"T273","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A274","pred":"fma_id","subj":"T274","obj":"http://purl.org/sig/ont/fma/fma265130"},{"id":"A275","pred":"fma_id","subj":"T275","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A276","pred":"fma_id","subj":"T276","obj":"http://purl.org/sig/ont/fma/fma82739"},{"id":"A277","pred":"fma_id","subj":"T277","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T14","span":{"begin":3606,"end":3611},"obj":"Body_part"},{"id":"T15","span":{"begin":4474,"end":4478},"obj":"Body_part"},{"id":"T16","span":{"begin":4497,"end":4514},"obj":"Body_part"},{"id":"T17","span":{"begin":5343,"end":5349},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T232","span":{"begin":306,"end":309},"obj":"Disease"},{"id":"T234","span":{"begin":1110,"end":1119},"obj":"Disease"},{"id":"T235","span":{"begin":2057,"end":2060},"obj":"Disease"},{"id":"T236","span":{"begin":2384,"end":2386},"obj":"Disease"},{"id":"T237","span":{"begin":4112,"end":4115},"obj":"Disease"},{"id":"T238","span":{"begin":4147,"end":4150},"obj":"Disease"},{"id":"T240","span":{"begin":4275,"end":4278},"obj":"Disease"},{"id":"T242","span":{"begin":4382,"end":4385},"obj":"Disease"},{"id":"T243","span":{"begin":4773,"end":4776},"obj":"Disease"},{"id":"T244","span":{"begin":4801,"end":4804},"obj":"Disease"},{"id":"T245","span":{"begin":4817,"end":4820},"obj":"Disease"},{"id":"T246","span":{"begin":5358,"end":5368},"obj":"Disease"},{"id":"T247","span":{"begin":5382,"end":5387},"obj":"Disease"}],"attributes":[{"id":"A232","pred":"mondo_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A233","pred":"mondo_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"},{"id":"A234","pred":"mondo_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A235","pred":"mondo_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A236","pred":"mondo_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/MONDO_0010526"},{"id":"A237","pred":"mondo_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A238","pred":"mondo_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A239","pred":"mondo_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"},{"id":"A240","pred":"mondo_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A241","pred":"mondo_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"},{"id":"A242","pred":"mondo_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A243","pred":"mondo_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A244","pred":"mondo_id","subj":"T244","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A245","pred":"mondo_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A246","pred":"mondo_id","subj":"T246","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A247","pred":"mondo_id","subj":"T247","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T532","span":{"begin":100,"end":106},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_33208"},{"id":"T533","span":{"begin":320,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T534","span":{"begin":320,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T535","span":{"begin":351,"end":353},"obj":"http://purl.obolibrary.org/obo/CLO_0003414"},{"id":"T536","span":{"begin":383,"end":386},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"},{"id":"T537","span":{"begin":480,"end":481},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T538","span":{"begin":485,"end":486},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T539","span":{"begin":584,"end":585},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T540","span":{"begin":629,"end":634},"obj":"http://purl.obolibrary.org/obo/CLO_0007836"},{"id":"T541","span":{"begin":797,"end":802},"obj":"http://purl.obolibrary.org/obo/CLO_0007836"},{"id":"T542","span":{"begin":812,"end":815},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T543","span":{"begin":841,"end":844},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T544","span":{"begin":944,"end":948},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T545","span":{"begin":988,"end":995},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9479"},{"id":"T546","span":{"begin":1184,"end":1186},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T547","span":{"begin":1286,"end":1288},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T548","span":{"begin":1388,"end":1391},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T549","span":{"begin":1442,"end":1444},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T550","span":{"begin":1491,"end":1495},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T551","span":{"begin":1508,"end":1509},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T552","span":{"begin":1561,"end":1563},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T553","span":{"begin":1768,"end":1770},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T554","span":{"begin":1808,"end":1813},"obj":"http://purl.obolibrary.org/obo/CLO_0001040"},{"id":"T555","span":{"begin":1973,"end":1975},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T556","span":{"begin":2022,"end":2026},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T557","span":{"begin":2375,"end":2379},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T558","span":{"begin":2568,"end":2570},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T559","span":{"begin":2592,"end":2597},"obj":"http://purl.obolibrary.org/obo/CLO_0001040"},{"id":"T560","span":{"begin":2720,"end":2721},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T561","span":{"begin":3116,"end":3117},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T562","span":{"begin":3294,"end":3296},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T563","span":{"begin":3308,"end":3309},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T564","span":{"begin":3369,"end":3371},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T565","span":{"begin":3490,"end":3491},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T566","span":{"begin":3606,"end":3611},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T567","span":{"begin":3634,"end":3636},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T568","span":{"begin":3648,"end":3649},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T569","span":{"begin":3659,"end":3662},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"},{"id":"T570","span":{"begin":3680,"end":3686},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9837"},{"id":"T571","span":{"begin":3735,"end":3741},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9837"},{"id":"T572","span":{"begin":3774,"end":3777},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T573","span":{"begin":3821,"end":3822},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T574","span":{"begin":3854,"end":3860},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9837"},{"id":"T575","span":{"begin":3982,"end":3989},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T576","span":{"begin":3994,"end":4000},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9837"},{"id":"T577","span":{"begin":4074,"end":4075},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T578","span":{"begin":4322,"end":4326},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T579","span":{"begin":4474,"end":4478},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T580","span":{"begin":4474,"end":4478},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T581","span":{"begin":4551,"end":4558},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T582","span":{"begin":4574,"end":4575},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T583","span":{"begin":4589,"end":4590},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T584","span":{"begin":4712,"end":4713},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T585","span":{"begin":4717,"end":4718},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T586","span":{"begin":4912,"end":4917},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T587","span":{"begin":5002,"end":5007},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T588","span":{"begin":5147,"end":5148},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T589","span":{"begin":5174,"end":5179},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T590","span":{"begin":5180,"end":5188},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9443"},{"id":"T591","span":{"begin":5280,"end":5283},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T261","span":{"begin":241,"end":248},"obj":"Chemical"},{"id":"T262","span":{"begin":259,"end":266},"obj":"Chemical"},{"id":"T263","span":{"begin":320,"end":322},"obj":"Chemical"},{"id":"T264","span":{"begin":364,"end":366},"obj":"Chemical"},{"id":"T265","span":{"begin":549,"end":556},"obj":"Chemical"},{"id":"T266","span":{"begin":573,"end":580},"obj":"Chemical"},{"id":"T267","span":{"begin":607,"end":616},"obj":"Chemical"},{"id":"T268","span":{"begin":944,"end":946},"obj":"Chemical"},{"id":"T270","span":{"begin":950,"end":952},"obj":"Chemical"},{"id":"T272","span":{"begin":956,"end":958},"obj":"Chemical"},{"id":"T274","span":{"begin":966,"end":968},"obj":"Chemical"},{"id":"T276","span":{"begin":1187,"end":1194},"obj":"Chemical"},{"id":"T277","span":{"begin":1491,"end":1493},"obj":"Chemical"},{"id":"T279","span":{"begin":1564,"end":1571},"obj":"Chemical"},{"id":"T280","span":{"begin":1733,"end":1735},"obj":"Chemical"},{"id":"T281","span":{"begin":2022,"end":2024},"obj":"Chemical"},{"id":"T283","span":{"begin":2129,"end":2131},"obj":"Chemical"},{"id":"T284","span":{"begin":2205,"end":2207},"obj":"Chemical"},{"id":"T285","span":{"begin":2387,"end":2394},"obj":"Chemical"},{"id":"T286","span":{"begin":2542,"end":2544},"obj":"Chemical"},{"id":"T287","span":{"begin":2767,"end":2769},"obj":"Chemical"},{"id":"T288","span":{"begin":2861,"end":2868},"obj":"Chemical"},{"id":"T289","span":{"begin":3018,"end":3020},"obj":"Chemical"},{"id":"T290","span":{"begin":3149,"end":3151},"obj":"Chemical"},{"id":"T291","span":{"begin":3276,"end":3283},"obj":"Chemical"},{"id":"T292","span":{"begin":3297,"end":3304},"obj":"Chemical"},{"id":"T293","span":{"begin":3637,"end":3644},"obj":"Chemical"},{"id":"T294","span":{"begin":4063,"end":4070},"obj":"Chemical"},{"id":"T295","span":{"begin":4322,"end":4324},"obj":"Chemical"},{"id":"T297","span":{"begin":4328,"end":4330},"obj":"Chemical"},{"id":"T299","span":{"begin":4334,"end":4336},"obj":"Chemical"},{"id":"T301","span":{"begin":4345,"end":4347},"obj":"Chemical"},{"id":"T303","span":{"begin":4551,"end":4558},"obj":"Chemical"},{"id":"T304","span":{"begin":4744,"end":4754},"obj":"Chemical"},{"id":"T305","span":{"begin":4744,"end":4749},"obj":"Chemical"},{"id":"T306","span":{"begin":4750,"end":4754},"obj":"Chemical"},{"id":"T307","span":{"begin":4855,"end":4863},"obj":"Chemical"},{"id":"T308","span":{"begin":4864,"end":4873},"obj":"Chemical"},{"id":"T309","span":{"begin":4894,"end":4903},"obj":"Chemical"},{"id":"T313","span":{"begin":4948,"end":4950},"obj":"Chemical"},{"id":"T314","span":{"begin":5039,"end":5047},"obj":"Chemical"},{"id":"T315","span":{"begin":5410,"end":5415},"obj":"Chemical"}],"attributes":[{"id":"A261","pred":"chebi_id","subj":"T261","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A262","pred":"chebi_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A263","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A264","pred":"chebi_id","subj":"T264","obj":"http://purl.obolibrary.org/obo/CHEBI_50653"},{"id":"A265","pred":"chebi_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A266","pred":"chebi_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A267","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_84491"},{"id":"A268","pred":"chebi_id","subj":"T268","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A269","pred":"chebi_id","subj":"T268","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A270","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A271","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A272","pred":"chebi_id","subj":"T272","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A273","pred":"chebi_id","subj":"T272","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A274","pred":"chebi_id","subj":"T274","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A275","pred":"chebi_id","subj":"T274","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A276","pred":"chebi_id","subj":"T276","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A277","pred":"chebi_id","subj":"T277","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A278","pred":"chebi_id","subj":"T277","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A279","pred":"chebi_id","subj":"T279","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A280","pred":"chebi_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A281","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A282","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A283","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A284","pred":"chebi_id","subj":"T284","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A285","pred":"chebi_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A286","pred":"chebi_id","subj":"T286","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A288","pred":"chebi_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A289","pred":"chebi_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A290","pred":"chebi_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A291","pred":"chebi_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A292","pred":"chebi_id","subj":"T292","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A293","pred":"chebi_id","subj":"T293","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A294","pred":"chebi_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A295","pred":"chebi_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A296","pred":"chebi_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A297","pred":"chebi_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A298","pred":"chebi_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A299","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A300","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A301","pred":"chebi_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A302","pred":"chebi_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A303","pred":"chebi_id","subj":"T303","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A304","pred":"chebi_id","subj":"T304","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"},{"id":"A305","pred":"chebi_id","subj":"T305","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A306","pred":"chebi_id","subj":"T306","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A307","pred":"chebi_id","subj":"T307","obj":"http://purl.obolibrary.org/obo/CHEBI_28984"},{"id":"A308","pred":"chebi_id","subj":"T308","obj":"http://purl.obolibrary.org/obo/CHEBI_16234"},{"id":"A309","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_18367"},{"id":"A310","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_26020"},{"id":"A311","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_35780"},{"id":"A312","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_43474"},{"id":"A313","pred":"chebi_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/CHEBI_9516"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A315","pred":"chebi_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":1110,"end":1119},"obj":"Phenotype"},{"id":"T13","span":{"begin":5382,"end":5387},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T77","span":{"begin":134,"end":158},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T78","span":{"begin":134,"end":158},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T79","span":{"begin":134,"end":158},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T80","span":{"begin":143,"end":158},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T81","span":{"begin":903,"end":928},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T82","span":{"begin":903,"end":928},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T83","span":{"begin":903,"end":928},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T84","span":{"begin":1454,"end":1479},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T85","span":{"begin":1454,"end":1479},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T86","span":{"begin":1454,"end":1479},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T87","span":{"begin":1985,"end":2010},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T88","span":{"begin":1985,"end":2010},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T89","span":{"begin":1985,"end":2010},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T90","span":{"begin":3954,"end":3968},"obj":"http://purl.obolibrary.org/obo/GO_0019076"},{"id":"T91","span":{"begin":4288,"end":4313},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T92","span":{"begin":4288,"end":4313},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T93","span":{"begin":4288,"end":4313},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T94","span":{"begin":5388,"end":5396},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T95","span":{"begin":5388,"end":5396},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T96","span":{"begin":5388,"end":5396},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T97","span":{"begin":5388,"end":5396},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
2_test
{"project":"2_test","denotations":[{"id":"32265848-28807998-36511173","span":{"begin":505,"end":509},"obj":"28807998"},{"id":"32265848-25405618-36511174","span":{"begin":1158,"end":1162},"obj":"25405618"},{"id":"32265848-26629538-36511175","span":{"begin":1164,"end":1168},"obj":"26629538"},{"id":"32265848-25874632-36511180","span":{"begin":2336,"end":2340},"obj":"25874632"},{"id":"32265848-25640653-36511181","span":{"begin":2356,"end":2360},"obj":"25640653"},{"id":"32265848-29496347-36511182","span":{"begin":2375,"end":2379},"obj":"29496347"},{"id":"32265848-27750111-36511183","span":{"begin":2844,"end":2848},"obj":"27750111"},{"id":"32265848-26218507-36511185","span":{"begin":3629,"end":3633},"obj":"26218507"},{"id":"32265848-30832356-36511186","span":{"begin":4053,"end":4057},"obj":"30832356"},{"id":"32265848-27899228-36511187","span":{"begin":4542,"end":4546},"obj":"27899228"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T235","span":{"begin":0,"end":44},"obj":"Sentence"},{"id":"T236","span":{"begin":45,"end":191},"obj":"Sentence"},{"id":"T237","span":{"begin":192,"end":248},"obj":"Sentence"},{"id":"T238","span":{"begin":249,"end":392},"obj":"Sentence"},{"id":"T239","span":{"begin":394,"end":509},"obj":"Sentence"},{"id":"T240","span":{"begin":510,"end":556},"obj":"Sentence"},{"id":"T241","span":{"begin":557,"end":662},"obj":"Sentence"},{"id":"T242","span":{"begin":664,"end":1168},"obj":"Sentence"},{"id":"T243","span":{"begin":1169,"end":1254},"obj":"Sentence"},{"id":"T244","span":{"begin":1256,"end":1545},"obj":"Sentence"},{"id":"T245","span":{"begin":1546,"end":1712},"obj":"Sentence"},{"id":"T246","span":{"begin":1714,"end":2379},"obj":"Sentence"},{"id":"T247","span":{"begin":2380,"end":2521},"obj":"Sentence"},{"id":"T248","span":{"begin":2523,"end":2848},"obj":"Sentence"},{"id":"T249","span":{"begin":2849,"end":2997},"obj":"Sentence"},{"id":"T250","span":{"begin":2999,"end":3230},"obj":"Sentence"},{"id":"T251","span":{"begin":3231,"end":3293},"obj":"Sentence"},{"id":"T252","span":{"begin":3294,"end":3331},"obj":"Sentence"},{"id":"T253","span":{"begin":3333,"end":3633},"obj":"Sentence"},{"id":"T254","span":{"begin":3634,"end":3668},"obj":"Sentence"},{"id":"T255","span":{"begin":3670,"end":4057},"obj":"Sentence"},{"id":"T256","span":{"begin":4058,"end":4097},"obj":"Sentence"},{"id":"T257","span":{"begin":4099,"end":4546},"obj":"Sentence"},{"id":"T258","span":{"begin":4547,"end":4738},"obj":"Sentence"},{"id":"T259","span":{"begin":4739,"end":5416},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T733","span":{"begin":34,"end":38},"obj":"SP_9"},{"id":"T19177","span":{"begin":34,"end":38},"obj":"SP_9"}],"text":"TABLE 2 Subunit Vaccines against MERS-CoVa.\nName Functionality and antigenicity Adjuvant Route Animal models Antibody response Cellular immune response Protective efficacy References\nSubunit vaccines based on MERS-CoV full-length S protein\nMERS S-2P protein Binds to DPP4 receptor and MERS-CoV S-NTD, RBD, and S2-specific neutralizing mAbs (G2, D12, and G4, respectively) SAS I.M. BALB/c mice Elicits neutralizing Abs in mice, neutralizing 7 pseudotyped MERS-CoV N/A N/A Pallesen et al., 2017\nSubunit vaccines based on MERS-CoV RBD protein\nrRBD (S367-606) protein N/A Alum Hydro + CpG or poly(I:C); IFA + CpG (mouse); Alum (NHPs) I.M. or S.C. BALB/c mice; NHPs Elicits MERS-CoV RBD-specific Abs in mice (IgG, IgG1, IgG2a, and IgG2b) and NHPs (IgG), neutralizing pseudotyped (mouse: \u003c 1:5 × 102) and live (NHPs: \u003c 1:5 × 102) MERS-CoV (EMC2012 strain) Induces MERS-CoV RBD-specific cellular immune responses (IFN-γ, TNF-α, IL-2, IL-4, IL-6, and IL-10) in mice and/or monkeys Partially protects vaccinated NHPs from challenge of MERS-CoV (EMC2012 strain, 6.5 × 107 TCID50) with alleviated pneumonia and decreased viral load Lan et al., 2014, 2015\nRBD (S377-662)-Fc protein Binds to DPP4 receptor Poly(I:C); Montanide I.N. or S.C. BALB/c mice Elicits MERS-CoV S1- and RBD-specific Abs (IgA, IgG (\u003e 1:104), IgG1, IgG2a, and IgG3) in mice, neutralizing (≥ 1:2.4 × 102) live MERS-CoV (EMC2012 strain) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice N/A Du et al., 2013c; Ma et al., 2014b\nRBD (S377-588)-Fc protein Binds to DPP4 receptor and MERS-CoV RBD specific neutralizing mAbs (Mersmab1, m336, m337, and m338) Montanide; MF59; AddaVax I.M. or S.C. BALB/c mice; hDPP4-Tg mice; Rabbits Elicits MERS-CoV S1 and RBD-specific Abs in mice (IgG (\u003e 1:105), IgG1, and IgG2a) and rabbits (IgG), neutralizing 17 pseudotyped (≥ 1:104) and 2 live (≥ 1:103) MERS-CoV (EMC2012 and London1-2012 strains) Induces MERS-CoV S1-specific cellular immune responses (IFN-γ and IL-2) in mice Protects vaccinated Ad5/hDPP4-transduced BALB/c mice and majority (4/6) of vaccinated hDPP4-Tg mice from MERS-CoV (EMC2012 strain, 105 PFU for BALB/c; 103–4 TCID50 for Tg) challenge, without immunological toxicity or eosinophilic immune enhancement Du et al., 2013a; Ma et al., 2014b; Tang et al., 2015; Zhang et al., 2016; Nyon et al., 2018\nRBD-Fd protein Binds to DPP4 receptor and MERS-CoV RBD-specific neutralizing mAbs (Mersmab1, m336, m337, and m338) MF59; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits MERS-CoV S1-specific Abs (IgG (\u003e 1:105), IgG1, and IgG2a) in mice, neutralizing at least 9 pseudotyped (\u003e 1:104) and live (\u003e 1:103) MERS-CoV (EMC2012 strain) N/A Protects majority (5/6) of vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Tai et al., 2016\nRBD (T579N) protein Binds to receptor DPP4 and MERS-CoV RBD-specific neutralizing mAbs (hMS-1, m336, m337, and m338) Montanide; Alum I.M. or S.C. BALB/c mice; hDPP4-Tg mice Elicits neutralizing Abs (\u003e 1:3 × 103) in mice against live MERS-CoV (EMC2012 strain) N/A Protects all vaccinated hDPP4-Tg mice from challenge of MERS-CoV (EMC2012 strain, 104 TCID50) Du et al., 2016a\nSubunit vaccines based on non-RBD MERS-CoV S protein fragments\nS1 protein N/A Ribi; Alum pho I.M. BALB/c mice; NHPs Elicits MERS-CoV S1-specific Abs in mice (IgG and IgG1) and NHPs (IgG), neutralizing 8 pseudotyped and live MERS-CoV (JordanN3 strain) N/A Protects vaccinated NHPs from challenge of MERS-CoV (JordanN3 strain, 5 × 106 PFU) with reduced abnormalities on chest CT Wang et al., 2015\nS1 protein N/A Advax + SAS I.M. Dromedary camels; Alpacas Elicits neutralizing Abs in dromedary camels (≥ 1:80) and alpacas (≥ 1:6.4 × 102) against live MERS-CoV (EMC2012 strain) N/A Protects vaccinated dromedary camels and alpacas from challenge of MERS-CoV (EMC2012 strain, 107 TCID50) with reduced and delayed viral shedding in the upper airways (in camels) or complete protection (in alpacas) Adney et al., 2019\nrNTD protein N/A Alum pho + CpG I.M. BALB/c mice; Ad5-hDPP4 mice Elicits MERS-CoV S-NTD-specific Abs (IgG, ≥ 1:104) in mice, neutralizing pseudotyped and live (1:40) MERS-CoV (EMC2012 strain) Induces MERS-CoV S-NTD-specific cellular immune responses (IFN-γ, IL-2, IL-6, IL-10, and IL-17A) in mice Protects vaccinated Ad5-hDPP4-transduced mice from challenge of MERS-CoV (EMC2012 strain, 105 PFU) with reduced lung abnormalities and respiratory tract pathology Jiaming et al., 2017\nSP3 peptide (aa736-761) N/A Freund’s N/A BALB/c mice; NZW rabbits Elicits MERS-CoV S-specific Abs (IgG, 1:104) in rabbits, neutralizing pseudotyped MERS-CoV N/A N/A Yang et al., 2014a\naaa, amino acid; Abs, antibodies; Ad5, adenovirus serotype 5; Ad5-hDPP4 mice, Ad5-hDPP4-transuced mice; Alum hydro, aluminum hydroxide; Alum pho, Aluminum phosphate; hDPP4, human dipeptidyl peptidase 4; hDPP4-Tg mice, transgenic mice expressing MERS-CoV receptor human DPP4; IFA, incomplete Freund’s adjuvant; I.M., intramuscular; I.N., intranasal; mAbs, monoclonal antibodies; Montanide, Montanide ISA51; N/A, not reported; NHPs, non-human primates; NZW, rabbits, New Zealand White rabbits; PFU, plaque-forming unit; rRBD, recombinant RBD; SAS, Sigma Adjuvant System; S.C., subcutaneous; TCID50, median tissue culture infectious dose; TNF-α, tumor necrosis factor (TNF)-alpha."}